Kimberlee Cobleigh Drapkin's most recent trade in LENZ Therapeutics Inc. was a trade of 13,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENZ Therapeutics Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Climb Bio Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 12,800 | 12,800 | - | 0 | Common Stock | |
| Climb Bio Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) |